These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 373736)

  • 1. Alternative pathway of complement activation by Candida albicans.
    Thong YH; Ferrante A
    Aust N Z J Med; 1978 Dec; 8(6):620-2. PubMed ID: 373736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the alternative complement pathway by Torulopsis glabrata.
    Ferrante A; Thong YH
    Scand J Infect Dis; 1979; 11(1):77-9. PubMed ID: 570297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans.
    Boxx GM; Nishiya CT; Kozel TR; Zhang MX
    Mol Immunol; 2009 Jan; 46(3):473-80. PubMed ID: 19038459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of mannan and glucan on complement activation and C3 binding by Candida albicans.
    Boxx GM; Kozel TR; Nishiya CT; Zhang MX
    Infect Immun; 2010 Mar; 78(3):1250-9. PubMed ID: 20028806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3.
    Luo S; Hartmann A; Dahse HM; Skerka C; Zipfel PF
    J Immunol; 2010 Aug; 185(4):2164-73. PubMed ID: 20644161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation and binding of C3 by Candida albicans.
    Kozel TR; Brown RR; Pfrommer GS
    Infect Immun; 1987 Aug; 55(8):1890-4. PubMed ID: 3301679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting roles of mannan-specific monoclonal immunoglobulin M antibodies in the activation of classical and alternative pathways by Candida albicans.
    Zhang MX; Cutler JE; Han Y; Kozel TR
    Infect Immun; 1998 Dec; 66(12):6027-9. PubMed ID: 9826391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mannan-specific immunoglobulin G antibodies in normal human serum accelerate binding of C3 to Candida albicans via the alternative complement pathway.
    Zhang MX; Kozel TR
    Infect Immun; 1998 Oct; 66(10):4845-50. PubMed ID: 9746588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the alternative (properdin) pathway of complement by Candida albicans and related species.
    Ray TL; Wuepper KD
    J Invest Dermatol; 1976 Dec; 67(6):700-3. PubMed ID: 794419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans.
    Kozel TR; Weinhold LC; Lupan DM
    Infect Immun; 1996 Aug; 64(8):3360-8. PubMed ID: 8757876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reactivity of Candida albicans in the system of the alternative way of complement activation].
    Zaslavskaia MI; Makhrova TV; Maianskiĭ AN
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (5):80-4. PubMed ID: 15554320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of complement by Naegleria.
    Rowan-Kelly B; Ferrante A; Thong YH
    Trans R Soc Trop Med Hyg; 1980; 74(3):333-6. PubMed ID: 7434428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways.
    Strunk RC; Eidlen DM; Mason RJ
    J Clin Invest; 1988 May; 81(5):1419-26. PubMed ID: 2966814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and secretion of complement proteins by macrophages.
    Colten HR; Ooi YM; Edelson PJ
    Ann N Y Acad Sci; 1979; 332():482-90. PubMed ID: 394641
    [No Abstract]   [Full Text] [Related]  

  • 15. Biological activities of naturally occurring antibodies reactive with Candida albicans mannan.
    Kozel TR; MacGill RS; Percival A; Zhou Q
    Infect Immun; 2004 Jan; 72(1):209-18. PubMed ID: 14688098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human alveolar macrophages synthesize the functional alternative pathway of complement and active C5 and C9 in vitro.
    Hetland G; Johnson E; Aasebø U
    Scand J Immunol; 1986 Nov; 24(5):603-8. PubMed ID: 3787189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil accumulation and cutaneous responses in experimental cutaneous candidiasis of genetically complement-deficient mice.
    Wilson BD; Sohnle PG
    Clin Immunol Immunopathol; 1988 Feb; 46(2):284-93. PubMed ID: 2827924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of the classical and alternative complement pathways in chemotaxis of human C2 deficiency (author's transl)].
    Pham Huu T; Buriot D; Griscelli C
    Ann Immunol (Paris); 1980; 131C(1):69-77. PubMed ID: 7396417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmin as a complement C5 convertase.
    Leung LL; Morser J
    EBioMedicine; 2016 Mar; 5():20-1. PubMed ID: 27077104
    [No Abstract]   [Full Text] [Related]  

  • 20. The secreted Candida albicans protein Pra1 disrupts host defense by broadly targeting and blocking complement C3 and C3 activation fragments.
    Luo S; Dasari P; Reiher N; Hartmann A; Jacksch S; Wende E; Barz D; Niemiec MJ; Jacobsen I; Beyersdorf N; Hünig T; Klos A; Skerka C; Zipfel PF
    Mol Immunol; 2018 Jan; 93():266-277. PubMed ID: 28860090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.